Verdad Advisers’s AMN Healthcare AMN Stock Holding History

Verdad Advisers’s Portfolio AMN Stock Details AMN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$917K	Buy	50,000 +5,000	+11%	+$95.1K	1.03%	27
2025 Q4	$709K	Buy	+45,000	New	+$803K	0.81%	46

Other funds holding AMN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Verdad Advisers's AMN Position: Q1 2026 in Review

Verdad Advisers increased its AMN Healthcare (AMN) stake by 11% in Q1 2026, buying an estimated $95.1K and bringing the position to 50,000 shares worth $917K. The position accounts for 1.03% of the portfolio, ranked #27.

Verdad Advisers first reported a position in AMN in Q4 2025 and has held it in 2 quarters since. 249 funds tracked by Wall St. Rank hold AMN as of Q1 2026.

Verdad Advisers held 50,000 shares of AMN Healthcare worth $917K as of Q1 2026.
Verdad Advisers bought 5,000 AMN Healthcare shares in Q1 2026, an estimated $95.1K.
AMN Healthcare made up 1.03% of Verdad Advisers's portfolio in Q1 2026, its #27 holding.
Verdad Advisers first reported a position in AMN Healthcare in Q4 2025 and has held it in 2 quarters since.
249 funds tracked by Wall St. Rank held AMN Healthcare as of Q1 2026.

Based on Verdad Advisers's 13F filing for Q1 2026, filed 15 May 2026.